Status:
WITHDRAWN
Cefoperazone/Sulbactam In The Treatment Of Serious Intra-Abdominal And Hepatobiliary Infections.
Lead Sponsor:
Pfizer
Conditions:
Abscess, Intra-Abdominal
Cholecystitis
Eligibility:
All Genders
18+ years
Brief Summary
The primary objective is to collect data on treatment outcomes (clinical and microbiological cure), safety and tolerability of treatment with cefoperazone/sulbactam in patients with serious intra-abdo...
Eligibility Criteria
Inclusion
- Male or female patient of age 18 years or older.
- Patient with intraabdominal/hepatobiliary infection.?
Exclusion
- Patients with known hypersensitivity to penicillins, cephalosporins, cefoperazone or to sulbactam.
Key Trial Info
Start Date :
May 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00463762
Start Date
May 1 2007
Last Update
April 22 2011
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.